全文获取类型
收费全文 | 1615篇 |
免费 | 105篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 46篇 |
妇产科学 | 52篇 |
基础医学 | 198篇 |
口腔科学 | 55篇 |
临床医学 | 137篇 |
内科学 | 417篇 |
皮肤病学 | 24篇 |
神经病学 | 46篇 |
特种医学 | 200篇 |
外科学 | 142篇 |
综合类 | 87篇 |
预防医学 | 45篇 |
眼科学 | 4篇 |
药学 | 82篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 181篇 |
出版年
2018年 | 22篇 |
2017年 | 15篇 |
2016年 | 19篇 |
2015年 | 24篇 |
2014年 | 34篇 |
2013年 | 32篇 |
2012年 | 34篇 |
2011年 | 27篇 |
2010年 | 36篇 |
2009年 | 50篇 |
2008年 | 42篇 |
2007年 | 43篇 |
2006年 | 58篇 |
2005年 | 41篇 |
2004年 | 34篇 |
2003年 | 39篇 |
2002年 | 31篇 |
2001年 | 23篇 |
2000年 | 39篇 |
1999年 | 24篇 |
1998年 | 47篇 |
1997年 | 58篇 |
1996年 | 53篇 |
1995年 | 38篇 |
1994年 | 38篇 |
1993年 | 38篇 |
1992年 | 39篇 |
1991年 | 30篇 |
1990年 | 40篇 |
1989年 | 40篇 |
1988年 | 38篇 |
1987年 | 34篇 |
1986年 | 27篇 |
1985年 | 29篇 |
1984年 | 33篇 |
1983年 | 25篇 |
1982年 | 27篇 |
1981年 | 21篇 |
1980年 | 21篇 |
1979年 | 24篇 |
1978年 | 25篇 |
1977年 | 25篇 |
1976年 | 28篇 |
1975年 | 31篇 |
1974年 | 28篇 |
1973年 | 29篇 |
1972年 | 31篇 |
1971年 | 24篇 |
1970年 | 21篇 |
1969年 | 21篇 |
排序方式: 共有1727条查询结果,搜索用时 15 毫秒
1.
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy 总被引:4,自引:0,他引:4
K L Griem I C Henderson R Gelman D Ascoli B Silver A Recht R L Goodman S Hellman J R Harris 《Journal of clinical oncology》1987,5(10):1546-1555
The use of adjuvant radiation therapy in breast cancer patients treated with mastectomy and adjuvant chemotherapy has been controversial. In order to assess the necessity and effectiveness of adjuvant radiation therapy in this setting, we reviewed the results in 510 patients with T1-T3 tumors and pathologically positive nodes or tumors larger than 5 cm and negative nodes who were treated with adjuvant chemotherapy. Patients with four or more positive nodes or at least one positive apical node were randomized to receive either five or ten cycles of cyclophosphamide/Adriamycin (Adria Laboratories, Columbus, OH) (CA) and patients with one to three positive nodes or operable tumors larger than 5 cm and pathologically negative nodes were randomized to receive eight cycles of either cyclophosphamide, methotrexate, and 5-fluorouracil (5-FU) (CMF) or methotrexate and 5-FU (MF) chemotherapy. Two hundred six of these patients were subsequently rerandomized to receive either no further treatment or adjuvant radiotherapy. Thirty-five patients withdrew after randomization, including 34 who declined to receive radiotherapy. Radiation therapy consisted of 4,500 cGy in 5 weeks to the chest wall and appropriate draining lymph nodes. Median follow-up from chemotherapy randomization is 45 months for patients in the CA arm and 53 months for those in the CMF/MF arm. The crude rate of local failure (chest wall or draining lymph node areas) as first site of failure for patients randomized to receive chemotherapy only was 14%; for those randomized to receive both chemotherapy and radiotherapy it was 5% (P = .03). For patients in the CMF/MF arm, the rate of local failure as the first site of failure was nearly the same for patients randomized to chemotherapy only as for those randomized to adjuvant radiotherapy as well (5% v 2%). For patients in the CA arm, the crude rate of local failure was 20% for patients randomized to receive chemotherapy only, and 6% for those randomized to both types of adjuvant treatment (P = .03). Among the 43 patients treated with CA who actually received radiotherapy, there was only one local failure, compared with 12 local failures among the 59 patients (20%) who actually did not receive radiotherapy (P = .007). No significant difference was seen in disease-free survival or overall survival in either the CA or the CMF/MF arm between patients randomized to receive radiation therapy and those randomized to no further treatment.(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
2.
Xiaoguang Zhu Raymond Q Migrino Robert S Hellman Tejas Brahmbhatt Ming Zhao 《Nuclear medicine communications》2008,29(9):764-769
OBJECTIVE: The C2A domain of Synaptotagmin I is a molecular probe for the specific imaging of cell death. Here we test the hypothesis that the uptake of 99mTc-C2A in the acute phase of an infarction is associated with cardiac dysfunction in follow-ups. METHODS: The left coronary artery was occluded in Sprague-Dawley rats for 0, 10, 20, and 30 min. 99mTc-C2A was injected intravenously at 2 h of reperfusion. Anterior planar images were acquired with one million counts on a gamma camera 3 h after injection. 99mTc-C2A uptake was calculated as the total counts in the left ventricle region minus blood pool signal. The in-vivo signal detected was correlated with wall motion score index at 1 and 3 weeks follow-ups measured by echocardiography. RESULTS: 99mTc-C2A uptake was higher with increased ischemic time (2244+/-852, 4054+/-1223, and 6178+/-1451 for 10, 20, and 30 min ischemia, analysis of variance P<0.001). A significant correlation was found between 99mTc-C2A uptake and wall motion score index at 1 week (R=0.800, P=0.0006) and 3 weeks (R=0.810, P=0.0008). CONCLUSION: In this ischemia/reperfusion model, 99mTc-C2A uptake in the acute phase was associated with functional abnormality at 1 and 3 weeks. This demonstrates the potential diagnostic and prognostic value of 99mTc-C2A as a novel imaging agent. 相似文献
3.
4.
5.
De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS 《Human reproduction (Oxford, England)》1997,12(2):357-360
We report the results of administration of danazol after suspension of
gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine
myomas. A total of 21 women with uterine myomas was treated with 100 mg
danazol for 6 months after GnRHa therapy. Uterine volume and endocrine
status were monitored monthly by ultrasound and assay of plasma
gonadotrophins, oestradiol and progesterone. The results show a rebound of
uterine volume about 30% less than in controls at the end of danazol
therapy. Menstrual cyclicity returned after 65 +/- 3 days in 16 subjects
and five patients remained amenorrhoeic. Hormone assays confirmed renewed
ovarian function in the women whose menstrual periods returned. Bone
mineral content was substantially reduced during GnRHa treatment but
improved significantly during danazol therapy even in the women who
remained amenorrhoeic. These results show the utility of danazol in
prolonging the therapeutic effects of GnRHa. The mechanism by which danazol
inhibits rebound of uterine volume may be due to its antiprogesterone
effects on uterine myomas.
相似文献
6.
7.
The authors report the clinical and laboratory findings of a patient who had severe immune hemolytic anemia due to hydrochlorothiazide (HCTZ). In this case, the HCTZ antibody reacted not only with other thiazide and thiazide-like drugs, but also with a chemically unrelated diuretic, ethacrynic acid. These results indicate that HCTZ antibody activity is not restricted solely to the thiazides and imply that therapy with any of the reactive drugs would be contraindicated for this patient. The serologic screening for drug reactivity may be useful for selecting alternative therapy for patients with drug-induced immune hemolytic anemia. 相似文献
8.
P L Tisdale B D Collier H M Kauffman M B Adams A T Isitman R S Hellman R G Hoffmann S A Rao T Joestgen L Krohn 《Journal of nuclear medicine》1986,27(8):1266-1272
A prospective evaluation of 111In-labeled platelet scintigraphy (IPS) for the early diagnosis of acute postoperative renal transplant rejection (TR) was undertaken. The results of IPS were compared with in vitro biochemical tests, the clinical finding of graft tenderness, and combined [99mTc]DTPA and [131I]orthoiodohippurate scintigraphy. With a sensitivity of 0.93 and a specificity of 0.95, IPS provided otherwise unavailable diagnostic information. Furthermore, postoperative IPS was a good predictor of long-term allograft survival. 相似文献
9.
10.